BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210906T120000
DTEND;TZID=Europe/Brussels:20210908T120000
DTSTAMP:20210408T113835Z
CREATED:20210408T113835Z
LAST-MODIFIED:20210408T113835Z
UID:2030-1630929600-1631102400@www.europabio.org
SUMMARY:International Conference on Renewable Resources & Biorefineries
DESCRIPTION:The 17th edition of the International Conference on Renewable Resources & Biorefineries will take place in Aveiro\, Portugal from Monday 6 Sept until Wednesday 8 Sept\, 2021. Based on the previous RRB conferences\, this conference is expected to welcome about 350 international participants from over 30 countries. \n\n\n\nDelegates from university\, industry\, governmental and non-governmental organizations\, and venture capital providers will present their views on industrial biotechnology\, sustainable (green) chemistry\, and agricultural policy related to the use of renewable raw materials for non-food applications and energy supply. The conference further aims at providing an overview of the scientific\, technical\, economic\, environmental\, and social issues of renewable resources and biorefineries in order to give an impetus to the biobased economy and to present new developments in this area. The conference will provide a forum for leading political\, corporate\, academic\, and financial people to discuss recent developments and set up collaborations.The three-day international conference will consist of plenary lectures\, oral presentations\, poster sessions\, and an exhibition. Companies and research organizations are offered the opportunity to organize a satellite symposium. \n\n\n\n \n\n\n\n\nRegister here
URL:https://www.europabio.org/event/international-conference-on-renewable-resources-biorefineries/
LOCATION:University of Aveiro\, Santiago Campus\, 3810-193 Aveiro\, Aveiro\, Portugal
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/04/Event-Banners-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210907T160000
DTEND;TZID=Europe/Brussels:20210907T170000
DTSTAMP:20210903T072658Z
CREATED:20210715T095059Z
LAST-MODIFIED:20210903T072658Z
UID:2936-1631030400-1631034000@www.europabio.org
SUMMARY:Treatment without borders: the EU case for equitable patient access to advanced therapies
DESCRIPTION:The EU Pharmaceutical Strategy is looking to improve patients’ access to therapies for challenging and rare conditions. The EU legislation on cross-border healthcare is an important instrument to ensure patient access to the best available care. There is an urgent need to revise this legislation to enable EU patients to access novel advanced therapies and medicines for rare diseases when these are not available in their home country. \n\n\n\nEuropaBio’s Advanced Therapies Series continues with a virtual discussion on avenues for enhancing the access of EU patients to novel biotechnology-derived treatments on September 7\, 2021\, from 16h00 to 17h00 CET. \n\n\n\nA patient who is also actively engaged in patient advocacy will explain the value of advanced therapies for rare disease patients and the key challenges they encounter when accessing treatments outside their home countries. \n\n\n\nA panel of EU\, national\, and industry representatives will attempt to put forward solutions for securing equitable access to both specialised centres and to treatment for all EU patients in need. Among others\, they will seek to advise on how to tackle the following challenges: some treatment centres being less interested to treat cross-border patients\, the need for experience and expertise in rare diseases\, approval process and time for cross-border treatment\, lack of knowledge or experience of healthcare providers in requesting reimbursement for cross-border treatments\, difficulties in approving advanced therapy applications if not reimbursed in the home country\, etc. \n\n\n\nModerator \n\n\n\nBernard Grimm\, Healthcare Biotech Director\, EuropaBio \n\n\n\nSpeakers  \n\n\n\nJana Popova\, Executive Committee Member of the European Alliance of Neuromuscular Disorders Associations & EUPATI Patient Engagement Training Coordinator \n\n\n\nBrieuc Van Damme\, Director-General Healthcare\, RIZIV-INAMI \n\n\n\nMartin Dorazil\, Deputy Head of Unit\, DG Health\, European Commission \n\n\n\nDirk Vander Mijnsbrugge\, Vice President Medical Affairs Lead Rare Diseases International Developed Markets\, Pfizer \n\n\n\nIrina Grossenbacher\, Region Europe Patient Access Director\, Novartis Rare Diseases \n\n\n\nTomislav Sokol\, Member of the European Parliament\, EPP\, Croatia
URL:https://www.europabio.org/event/treatment-without-borders-the-eu-case-for-equitable-patient-access-to-advanced-therapies/
CATEGORIES:EuropaBio,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/07/NL-Size-28.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210920T090000
DTEND;TZID=Europe/Brussels:20210921T170000
DTSTAMP:20210628T201352Z
CREATED:20210210T200303Z
LAST-MODIFIED:20210628T201352Z
UID:1320-1632128400-1632243600@www.europabio.org
SUMMARY:German Biotechnology Days
DESCRIPTION:Germany’s largest biotech event\, the German Biotechnology Days 2021 (Deutsche Biotechnologietage\, DBT)\, will take place on 20th and 21st September in Stuttgart. With over 800 participants\, the event is regarded as the German class reunion for biotechnology. The DBT brings together entrepreneurs with scientists and partners from politics\, funding institutions and administration. \n\n\n\nIn plenary sessions and numerous symposia\, top-class speakers present and discuss the diverse fields of application and the potential of biotechnology\, from health research to bioeconomy\, from medicine to industrial production and plant breeding. Exchange and networking traditionally play a major role at the DBT. The big evening event on the first day of the conference is therefore a further highlight. In addition to the conference programme\, there will also be a large exhibition. \n\n\n\nThe German Biotechnology Days are jointly organised by BIO Deutschland and the Council of German BioRegions. The host region for 2021 is STERN BioRegion from Stuttgart. As a partner region\, we are looking forward to BioLAGO\, the network for the health industry in the Lake Constance region. \n\n\n\nAbout the organizersBIO Deutschland e. V.\, the industry association of the German biotechnology industry\, and the Council of German BioRegions have been jointly organising the German Biotechnology Days since 2010. The forum for the German biotechnology scene takes place annually at different locations. The regional host of the event is always a bioregion from the Council of German BioRegions\, often accompanied by a partner region. \n\n\n\n\nVIRTUAL EVENT \n \n\n\n\n\n\nRegister Here
URL:https://www.europabio.org/event/german-biotechnology-days/
LOCATION:BIO Deutschland\, Schützenstraße 6a\, Berlin\, D-10117\, Germany
CATEGORIES:External,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-DBT.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210921T143000
DTEND;TZID=Europe/Brussels:20210921T153000
DTSTAMP:20210922T093101Z
CREATED:20210831T112430Z
LAST-MODIFIED:20210922T093101Z
UID:3028-1632234600-1632238200@www.europabio.org
SUMMARY:EFIB Pre-event webinar
DESCRIPTION:Sustainability in industrial biotech innovations: life cycle assessment and beyond \n\n\n\nSponsored by DSM\n\n\n\n \n\n\n\n\n\nGet ready for EFIB 2021 by attending the kick-off webinar “Sustainability in Industrial biotech innovations: Life Cycle Assessment and beyond”\, which will take place on Tuesday 21 September 2021 from 14.30 – 15.30 CET. \n\n\n\nSustainability is the drive and purpose behind most industrial biotech innovations. But how to incorporate it in the innovation process? How to assess it\, measure it\, and use it for decision making? During this webinar we will explore: \n\n\n\n• How well-established tools like Life Cycle Assessment are being used in industrial biotech innovations \n\n\n\n• What are novel tools and methodologies relevant for the sustainability assessment of industrial biotech \n\n\n\n• How corporates\, start-ups and academia use these tools in their innovation process \n\n\n\nThis kick-off webinar by EuropaBio is co-hosted by Planet B.io\, the open innovation hub for industrial biotechnology\, located at the Biotech Campus Delft in The Netherlands. \n\n\n\nModerator:  \n\n\n\n •  Maria Cuellar-Soares | S&T Officer\, Planet B.io \n\n\n\nSpeakers: \n\n\n\n •  Ulla Létinois | Senior Scientist\, Sustainable Chemistry\, DSM \n\n\n\n •  Yang Xiang | Senior Corporate LCA Expert\, DSM \n\n\n\n •  Cristina Prat | Co-founder\, FUL Foods \n\n\n\n •  John Posada | Assistant Professor in Biotechnology and Society\, TU Delft \n\n\n\n\nSlides\n\n\n\n\nParticipation for this webinar is free of charge\, but registration is required. \n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/efib-pre-event-webinar/
CATEGORIES:EFIB
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/08/Event-Banners.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210927T080000
DTEND;TZID=Europe/Brussels:20211003T080000
DTSTAMP:20210610T122254Z
CREATED:20210128T134240Z
LAST-MODIFIED:20210610T122254Z
UID:948-1632729600-1633248000@www.europabio.org
SUMMARY:European Biotech Week 2021
DESCRIPTION:The European Biotech Week celebrates biotechnology\, an innovative and vibrant sector launched by the discovery of the DNA molecule back in 1953. The first European Biotech Week that took place in 2013 marked the 60th anniversary of this pivotal moment in history. \n \n 
URL:https://www.europabio.org/event/european-biotech-week-2021/
CATEGORIES:EuropaBio,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/European-Biotech-Week-Event-Banner-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210927T120000
DTEND;TZID=Europe/Brussels:20211001T120000
DTSTAMP:20210401T124400Z
CREATED:20210401T124400Z
LAST-MODIFIED:20210401T124400Z
UID:1932-1632744000-1633089600@www.europabio.org
SUMMARY:10th International Trade Show & Partnering
DESCRIPTION:The largest biotech event country based event in Europe \n\n\n\nBIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings (+3.300) and companies participating (+773). 34% of our delegates came from outside of Spain. \n\n\n\nWhy Spain? \n\n\n\nIn 2018 there were 751 dedicated biotechnology enterprises in Spain (+5\,33%)\, according to data in the AseBio Report 2019. Biotech companies have generated more than €8.2 billion in income\, roughly 0.7% of the national total. The biotechnology sector was responsible for more than 105\,000 direct\, indirect and induced jobs\, which is 0.6% of national employment. Over 27\,000 of these jobs were people employed directly by biotech companies. Biotechnology activities are at the top of rankings on production growth of economic activities for 2018\, up 10.1%.” \n\n\n\nEuropaBio Members can benefit of a 10% discount on the price. Please liaise with Martina Cilia (m.cilia@europabio.org) to receive detailed information on the discount code. \n\n\n\n\nRegister here
URL:https://www.europabio.org/event/10th-international-trade-show-partnering/
LOCATION:Auditorium & Trade Show Centre\, Plaza del Baluarte s/n\, 31002\, Pamplona\, Spain
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/04/Event-Banners.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210927T153000
DTEND;TZID=Europe/Brussels:20210927T170000
DTSTAMP:20210922T105308Z
CREATED:20210614T145612Z
LAST-MODIFIED:20210922T105308Z
UID:2714-1632756600-1632762000@www.europabio.org
SUMMARY:Biotechnology for society - Turning science into a sustainable and healthy world
DESCRIPTION:EuropaBio’s launch meeting for Biotech Week will share how science finds its way to an end use\, whether it is a new medicine\, or a product developed using new scientific processes.  \n\n\n\nEurope sets the global standard for consumer and environmental protection.  This translates into a regulatory framework for different sectors through which novel products must pass before they can be used in Europe.  The European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) are the gateway for new products and play a critical role in how Europe innovates safely. \n\n\n\nIt can be complicated\, particularly for new science. So how does Europe deliver innovation to benefit patients and our planet whilst ensuring the high standards and safety that we expect? \n\n\n\nThe Covid response from regulators demonstrated how Europe can be agile and rapid for the vaccines that are now helping Europe restore a safe and open society.  Our launch event for Biotech Week brings together the community that develops products from science to consumers\, highlighting how we can evolve our regulatory systems help develop safe societies and a competitive Europe. \n\n\n\nConfirmed speakers: \n\n\n\nAna Maria Bravo\, Director of Government Affairs\, IFFWolfgang Gelbmann\, Senior Scientific Officer\, Nutrition Unit\, EFSADamian Gilkerson\, CSL Behring Executive Director Therapeutic Area EU\, Commercial Operations EuropeEmmanuelle Voisin\, CEO Voisin Consulting Life Sciences\n\n\n\nJoin us to find out how science reaches its target and help EuropaBio kick start a week dedicated to the explanation and celebration of biotechnology. \n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/biotechnology-for-society-turning-science-into-a-sustainable-and-healthy-world/
CATEGORIES:Biotech Week
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/06/European-Biotech-Week-Event-Banner-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210929T120000
DTEND;TZID=Europe/Brussels:20210929T133000
DTSTAMP:20210929T123032Z
CREATED:20210614T150425Z
LAST-MODIFIED:20210929T123032Z
UID:2723-1632916800-1632922200@www.europabio.org
SUMMARY:Investing in healthcare - How can the revision of the general pharmaceutical legislation better attract investors in the future?
DESCRIPTION:The evaluation and revision of the general pharmaceutical legislation is the opportunity to create a future-proof\, patient-oriented and leading life science and biotechnology sector in the EU. \n\n\n\nThe first aim of this initiative should be to regain EU’s global leadership as a home for R&D and cutting-edge industry to secure high-quality care for citizens at affordable levels. \n\n\n\nNew biotechnology-derived vaccines and treatments have helped to tackle numerous life-threatening illnesses. Targeted treatments\, like cell and gene therapies\, and new mRNA platforms are paving the way for future treatments. COVID-19 has shown that only science-based and high-risk research embedded in a strong life science industry ecosystem can bring the lasting solutions to health challenges. \n\n\n\nEmerging biopharmaceutical companies account for over 70% of the research pipeline contributing to a vibrant sector. The EU biotech sector\, mostly made up of SMEs\, relies on robust IP and targeted incentives that enable companies to raise risk capital\, with the prospect of remaining unprofitable for years. It is due to these set of incentives that the EU has retained its capability to produce breakthrough innovation. To keep pace with the rest of the world\, future incentives should reflect the economic challenges of developing health innovation. \n\n\n\nJoin us to find out how investing in R&D for innovative medicines and treatments is essential to support a competitive European biotechnology industry. \n\n\n\nConfirmed speakers:: \n\n\n\n\nJuozas OLEKAS\, Member of the European Parliament\, S&D\, Lithuania \n\n\n\nStefan Gijssels\, SEBOIO Health Policy Consulting and Co-founder of digestive Cancer Europe \n\n\n\nIngrid Maes\, Co-founder of Inovigate\, 25 years of experience in Life Sciences Expertise in New Product Development and Market Introduction \n\n\n\nIsabelle Schubert\, Global Head IP Strategy at Novartis \n\n\n\nOskar Slotboom\, General Partner at BGV (BioGeneration Ventures) \n\n\n\n\nSlides\n\n\n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/investing-in-healthcare-how-can-the-revision-of-the-general-pharmaceutical-legislation-better-attract-investors-in-the-future/
LOCATION:Invest Europe
CATEGORIES:Biotech Week
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/06/European-Biotech-Week-Event-Banner-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210930T140000
DTEND;TZID=Europe/Brussels:20210930T150000
DTSTAMP:20211001T075124Z
CREATED:20210614T154210Z
LAST-MODIFIED:20211001T075124Z
UID:2727-1633010400-1633014000@www.europabio.org
SUMMARY:The small companies changing the world: Meet the science and business of sustainability
DESCRIPTION:With the Green Deal\, the EU has set an ambitious strategy towards climate neutrality\, transitioning to a circular economy and a more sustainable food system. Many aspects of our lives must change to achieve these ambitions: a reduction in only high profile targets\, such as transport\, will not be enough. Our food\, cosmetics\, clothes\, and other products and consumables across our lives need to get leaner and greener and biotechnology solutions can contribute towards responding to this need. \n\n\n\nConfirmed speakers: \n\n\n\nJuan Medina\, Co-Founder and CEO Kaffe BuenoTaichi Ochi\, Senior Business Developer\, EV BiotechCyrille Pauthenier\, CEO Abolis\n\n\n\nJoin us to find out how small companies across Europe are rising to the challenge to innovate for our sustainable futures. \n\n\n\n\nSlides\n\n\n\n\n\nREGISTER HERE
URL:https://www.europabio.org/event/the-small-companies-changing-the-world-meet-the-science-and-business-of-sustainability/
CATEGORIES:Biotech Week
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/06/European-Biotech-Week-Event-Banner-4.png
END:VEVENT
END:VCALENDAR